FDA Investigator Esteban Beltran

Esteban Beltran has conducted inspections on 84 sites in 17 countries as of 27 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
84
Last Inspection Date:
27 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100005392
Countries of Inspections:
United States of America, France, India, Germany, Japan, Dominican Republic, Israel, Switzerland, United Kingdom of Great Britain and Northern Ireland, Sweden, Malaysia, Italy, Costa Rica, Belgium, Singapore, Ireland, Monaco
FDA Investigators that have inspected at least one site in common with Esteban Beltran:
Addam S Reynolds, Adetutu M Gidado, Akbar J Zaidi, Alan L Truong, Alberto A Viciedo, Althea A Williams, Amy L Singer, Amy M Cramer, Andrew J Garufi, Angelica G Aziz, Anna M Brannen, Anthony M Criscuolo, Jr, Arsen Karapetyan, Ashley A Mutawakkil, Barbara Janine Breithaupt, Barbara Jwilimczyk Macri, Brandi L Garbutt, Brian S Keefer, Byungja E Marciante, Carla J Lundi, Carolina D Vasquez, Cary Greene, CDR Sean T Creighton, Charles J Chacko, Christina N Maurino, Christopher J Adams, Daniel J Grabicki, Daniel J Lahar, David H Smith, Dawn C Olenjack, Dawn L Wydner, Dawn M Mccabe, Deborah A Greco, Denise M Visco, Investigator, Dhaval H Patel, Diane B Radice, Dipesh K Shah, Dolores Harper, Donald J Ullstrom, Doreen P Gubbay, Douglas C Kovacs, Edward O'shaughnessy, Elizabeth D Connell, Emest F Bizjak, Emily A Walters, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Frank J Marciniak, Frederick F Razzaghi, Gam S Zamil, Glen C Lawrence, Gloria E Parra, Gobiga Vanniyasingam, Guerlain Ulysse, Helen B Ricalde, Hitesh R Patel, James R Birkenstamm, James R Montero, James W Plucinski, James W Whitney, Janete F Guardia, Jazmine M Welcher, Jean M Kelahan, Jennifer A Bazergui, Jennifer L Custodio, Jennifer Macmillan, Jennifer S Ness, Jessica M Monteiro, Jocelyn E Massey, John A Gonzalez, Jonee J Mearns, Jose M Cayuela, Joshua J Silvestri, Karen E D'orazio, Kelli F Dobilas, Kelly I Anderson, Kinh Q Mac, Kip J Hanks, Kish Bolden, Kristen E Rescigno, Kristy A Zielny, Kwong P Lee, Lacedric V Harris, Lauren E Skokan, Lauren L Vajo, Lawrence R Johnson, LCDR Wilfred A Darang, Li Li, Liatte Kreuger, PharmD, Lisa A Warner, Lisa Harlan, Lisa Mathew, Loretta Nemchik, Lori A Gioia, LT Colin E Tack, BSE, Maida Henesian (NMI), Marcus F Yambot, Margaret M Annes, Margaret M Sands, Maria Estrella, Matthew W Kyle, Melissa A Freeman, Melissa A Zuppe, Melissa T Roy, Meredith L Sheridan, Miaja Umaedi, Michael Serrano, Michelle S Dunaway, Miguel Gmanzano Maldonado, Monica L Gutierrez, Monika Borkowska, Naakesh N Gomanie, Nancy L Rolli, Nancy M Espinal, Natasha R Johnson, Nerizza B Guerin, Nicholas A Violand, Paul L Bellamy, Paul P Geraci, Peter Abel, Raymond L Cheung, Rebecca Co Bryan, Regina T Brown, Richard D Manney, Richard Jay Tucker, RS, Richard L Rutherford, Robert G Ruff, Robin P Mathew, Russell J Glapion, Santiago Gallardo Johnson, Sarah Forney, Schultz, Scott K Zika, Shawn E Larson, Stephanie A Cochran, Stephanie T Durso, Stephen C Smith, Stephen D Eich, Stephen J Mottola, Susan T Hadman, Tamala P Magee, Tania E Vizcaino, Teresa Y Bills, Terri E Gibson, Unnee Ranjan, Valerie C Reed, Valerie Reed, Wayne J Meyer, Wendy M Stone, William J Muszynski, William R Chang, Yumi J Hiramine, Yvesna C Blaise, Zachary A Bogorad

Esteban Beltran's Documents

Publish Date Document Type Title
January, 2020 FDA 483 E-BEAM Services, Inc. - Form 483, 2020-01-27
November, 2017 FDA 483 Ashland Specialty Ingredients, G.P. - Form 483, 2017-11-21
August, 2019 FDA 483 Westwood Laboratories, LLC. - Form 483, 2019-08-02
April, 2022 FDA 483 BIOTECH EUROPE MEDITECH Inc. Ltd - Form 483, 2022-04-14
August, 2017 FDA 483 Osteotech, Inc. - Form 483, 2017-08-10
June, 2022 FDA 483 Sanmina Sci Israel Medical Systems Ltd. - Form 483, 2022-06-16
September, 2022 FDA 483 Olympus Medical Systems Corporation - Form 483, 2022-09-09
October, 2016 FDA 483 Response RARITAN PHARMACEUTICALS INCORPORATED - Form 483R, 2016-11-03
August, 2018 FDA 483 KR Medical Technologies, LLC. - Form 483, 2018-08-03
March, 2018 FDA 483 Burpee Materials Technology, LLC - Form 483, 2018-03-14
August, 2018 FDA 483 Anesthetic Gas Reclamation Inc. - Form 483, 2018-08-09
September, 2019 FDA 483 M.D.L. S.r.l. - Form 483, 2019-09-19
November, 2022 FDA 483 Kitron AB - Form 483, 2022-11-10
January, 2023 FDA 483 FUJIFILM Healthcare Manufacturing Corporation Sano Office - Form 483, 2023-01-27
April, 2022 FDA 483 Nemaura Pharma Limited - Form 483, 2022-04-21
June, 2017 EIR Pacon Manufacturing Corporation - EIR, 2017-06-20
June, 2017 FDA 483 Pacon Manufacturing Corporation - Form 483, 2017-06-20
March, 2019 FDA 483 Suite K Value Added Services LLC - Form 483, 2019-03-07
October, 2016 FDA 483 RARITAN PHARMACEUTICALS INCORPORATED - Form 483, 2016-10-20
March, 2023 FDA 483 Icecure Medical Ltd - Form 483, 2023-03-22
August, 2017 FDA 483 LifeCell Corporation - Form 483, 2017-08-25
January, 2017 FDA 483 P.C. Marketing, Inc. - Form 483, 2017-01-19
January, 2024 EIR Systagenix Wound Management Manufacturing, Ltd - EIR, 2024-02-20
June, 2019 FDA 483 Premier Trends LLC - Form 483, 2019-06-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more